TickerFactsScreenerDevelopers

REGENXBIO Inc. (RGNX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$8.11M2013: -$13.92M2014: -$18.29M2015: $216.81M2016: $161.74M2017: $183.03M2018: $508.85M2019: $450.20M2020: $377.75M2021: $764.30M2022: $516.20M2023: $311.74M2024: $259.65M2025: $102.73M$102.73M
2012Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$102.73M-60.4%
2024$259.65M-16.7%
2023$311.74M-39.6%
2022$516.20M-32.5%
2021$764.30M+102.3%
2020$377.75M-16.1%
2019$450.20M-11.5%
2018$508.85M+178.0%
2017$183.03M+13.2%
2016$161.74M-25.4%
2015$216.81M+1285.3%
2014-$18.29M-31.4%
2013-$13.92M-71.6%
2012-$8.11M—